Commission Implementing Regulation (EU) No 489/2013 of 27 May 2013 amending the Annex to Regulation (EU) No 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, as regards the substance double stranded ribonucleic acid homologous to viral ribonucleic acid coding for part of the coat protein and part of the intergenic region of the Israel Acute Paralysis Virus
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XIII Medicinal Products
Joint committee decision (JCD)
039/2014 In force in the EEA
Yes Legal documents
Commission Implementing Regulation (EU) No 489/2013 of 27 May 2013 amending the Annex to Regulation (EU) No 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, as regards the substance double stranded ribonucleic acid homologous to viral ribonucleic acid coding for part of the coat protein and part of the intergenic region of the Israel Acute Paralysis Virus
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) nr. 489/2013 frá 27. maí 2013 um breytingu á viðaukanum við reglugerð (ESB) nr. 37/2010 um lyfjafræðilega virk efni og flokkun þeirra að því er varðar hámarksgildi leifa í matvælum úr dýraríkinu með tilliti til efnisins tvíþátta ríbósakjarnsýru sem samsvarar veiruríbósakjarnsýru sem kóðar fyrir hluta af hjúpprótíninu og hluta af milligenasvæðinu í ísraelsku bráðalömunarveirunni
Durchführungsverordnung (EU) Nr. 489/2013 der Kommission vom 27. Mai 2013 zur Änderung des Anhangs der Verordnung (EU) Nr. 37/2010 über pharmakologisch wirksame Stoffe und ihre Einstufung hinsichtlich der Rückstandshöchstmengen in Lebensmitteln tierischen Ursprungs in Bezug auf doppelsträngige Ribonukleinsäure homolog zu Virus-Ribonukleinsäure, die für einen Teil des Viruskapsids und einen Teil der intergenischen Region des Israelischen Akute-Bienen-Paralyse-Virus codiert
Kommisjonens gjennomføringsforordning (EU) nr. 489/2013 av 27. mai 2013 om endring av vedlegget til forordning (EU) nr. 37/2010 om farmakologisk virksomme stoffer og deres klassifisering med hensyn til grenseverdier for restmengder i næringsmidler av animalsk opprinnelse, når det gjelder stoffet dobbelttrådet ribonukleinsyre homolog til viral ribonukleinsyre som koder for en del av proteinkapselen og en del av den intergeniske regionen av israelsk akuttparalysevirus
History
09.04.2014
Adopted JCD confirmed entry into force date
09.04.2014
Compliance date in the EEA
08.04.2014
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
17.02.2014
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
27.05.2013
Adoption date in the EU
18.06.2013
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.